# Pulmocide > Pulmocide Ltd. is a privately held, clinical-stage biopharmaceutical company in London, United > Kingdom (with Pulmocide Inc. in Boston, Massachusetts) developing novel inhaled medicines for > pulmonary aspergillosis and other difficult-to-treat respiratory diseases. Its lead asset is > opelconazole (formerly PC945), an inhaled triazole antifungal active against Aspergillus. ## Important for agents Pulmocide publishes **no public API, no developer portal, no SDKs and no machine-readable API contract**. It is a drug developer, not a software or platform company. Verified by probe on 2026-08-26: /openapi.json, /openapi.yaml, /swagger.json, /v1/openapi.json, /api-docs, /docs, /redoc, /graphql, /llms.txt and every /.well-known/* path on pulmocide.com return HTTP 404. The corporate site runs WordPress, so https://pulmocide.com/wp-json/ answers 200 with the stock WordPress REST discovery document. That is default CMS and plugin infrastructure, not a product API — it is undocumented, unsupported, unversioned by the company, and must not be treated as a Pulmocide integration surface. There is no GitHub organization at github.com/pulmocide, and no package named "pulmocide" is published on npm or PyPI. ## Company - [Home](https://pulmocide.com/): Company overview and lead programs. - [Company Overview](https://pulmocide.com/about-us/): Mission, leadership and board. - [Aspergillosis](https://pulmocide.com/aspergillosis/): Disease background. - [Opelconazole](https://pulmocide.com/opelconazole/): Lead inhaled antifungal candidate. - [Portfolio](https://pulmocide.com/portfolio/): Pipeline overview. - [Investors & Partners](https://pulmocide.com/investors-and-partners/): Investor and partner information. - [In the News](https://pulmocide.com/in-the-news/): Press releases, publications and presentations. - [References](https://pulmocide.com/references/): Cited scientific literature. - [Contact](https://pulmocide.com/contact/): UK and US addresses, admin@pulmocide.com. ## Optional - [News feed (RSS)](https://pulmocide.com/feed/): Site RSS feed. - [Privacy Notice](https://pulmocide.com/privacy-notice/) - [Cookie Policy](https://pulmocide.com/cookie-policy/) - [Accessibility](https://pulmocide.com/accessibility/) ## Provenance Generated 2026-08-26 by the API Evangelist enrichment pipeline from apis.yml and live probes of pulmocide.com. Method: generated (no provider-published /llms.txt exists — 404).